homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

July 27, 2017

State gets $368,000 Medicaid settlement

OLYMPIA (AP) — Washington state will keep a small fraction of a $280 million national settlement involving a pharmaceutical company accused of committing fraud by promoting two drugs for unapproved cancer treatments.

Celgene Corp. denied wrongdoing but agreed to pay the federal government, 28 states and the District of Columbia to settle a whistleblower claim brought by a former company saleswoman. Washington state will keep about $368,000 for its Medicaid program under the settlement announced Tuesday. The whistleblower could be entitled to as much as $84 million.


 
. . .


To read this story in full login or purchase a subscription.




Email or user name:
Password:
 
Forgot password? Click here.